HMGB1 and myocardial ischemia: The inhibition of pro-inflammatory and apoptosis key players was an effect of ghrelin administration in multiple animal studies of myocardial ischemia/reperfusion injury through activation of different pathways, including inflammatory axes, such as High mobility group box 1 (HMGB1)/TLR4/NF-κB pathway [202,203].